Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and individualized intravenous voriconazole therapy in early post-liver transplant recipients
ChiCTR2100052870Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of voriconazole in Post-transplantation status (Post-Tx) and invasive mycoses, sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Plasma voriconazole concentrations and Voriconazole pharmacokinetic parameters. Started Jun 2021; status: recruiting.
02
Drugs
voriconazole
03
Conditions
Post-transplantation status (Post-Tx)invasive mycoses
Beyond the preview
Go deeper on ChiCTR2100052870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052870.